RAPT Therapeutics Inc. (RAPT)
1.11
-0.03 (-2.63%)
At close: Mar 03, 2025, 12:16 PM
RAPT Therapeutics Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
| Revenue | n/a | 1.53M | 3.81M | 5.04M | n/a | n/a | n/a |
| Cost of Revenue | 3.55M | 2.81M | 996K | n/a | 1.33M | 1.24M | 1.38M |
| Gross Profit | -3.55M | -1.28M | 2.82M | 5.04M | -1.33M | -1.24M | -1.38M |
| Operating Income | -127.06M | -85.8M | -69.21M | -53.21M | -43.63M | -36.95M | -29.33M |
| Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -116.8M | -83.84M | -69.2M | -51.9M | -42.34M | -36.15M | -29.11M |
| Net Income | -116.8M | -81.88M | -68.21M | -52.89M | -43M | -36.15M | -29.11M |
| Selling & General & Admin | 26.06M | 20.24M | 16.04M | 12.77M | 8.72M | 5.18M | 3.71M |
| Research & Development | 101M | 67.08M | 56.98M | 45.48M | 34.91M | 31.77M | 25.62M |
| Other Expenses | n/a | 1.96M | 5K | 1.31M | 1.29M | 800K | 216K |
| Operating Expenses | 127.06M | 87.32M | 73.02M | 58.26M | 43.63M | 36.95M | 29.33M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 127.06M | 87.32M | 73.02M | 58.26M | 43.63M | 36.95M | 29.33M |
| Income Tax | n/a | -1.96M | -996K | 990K | 660K | 800K | n/a |
| Shares Outstanding (Basic) | 38.34M | 32.54M | 27.39M | 24.13M | 21.83M | 17.33M | 14.46M |
| Shares Outstanding (Diluted) | 38.34M | 32.54M | 27.39M | 24.13M | 21.83M | 17.33M | 14.46M |
| EPS (Basic) | -3.05 | -2.52 | -2.49 | -2.19 | -1.97 | -2.09 | -2.01 |
| EPS (Diluted) | -3.05 | -2.52 | -2.49 | -2.19 | -1.97 | -2.09 | -2.01 |
| EBITDA | -125.85M | -84.75M | -68.21M | -52.09M | -42.3M | -35.71M | -27.95M |
| Depreciation & Amortization | 1.22M | 2.81M | 996K | 1.12M | 1.33M | 1.24M | 1.38M |